Therapeutic Area
Therapeutic Excellence
Building Predictable Vaccine Trials: Five Drivers to Protect Endpoints
In a vaccine study, the right sites must be ready at the right time—and every potential endpoint event must be captured and documented. Delays in activation, gaps in surveillance or missing specimens can put the evidence needed for a development decision at risk.
Download this paper to learn:
- Select countries and sites with a credible opportunity to capture endpoint events
- Align activation, enrollment and surveillance with the relevant disease window
- Identify where participant, site or specimen processes could compromise endpoint data
- Define signals that prompt timely review and action
- Prepare response options before changing conditions put study objectives at risk
Related Content
Looking for exclusive insight?
